下载掌阅APP，畅读海量书库
立即打开
1.Sugano, K. (2009). Introduction to computational oral absorption simulation. Expert Opin.Drug Metab. Toxicol ., 5, 259–293.
2.Pagliara, A., Carrupt, P.A., Caron, G., Gaillard, P., Testa, B. (1997). Lipophilicity Profiles of Ampholytes. Chem. Rev ., 97, 3385–3400.
3.Glomme, A., M¨arz, J., Dressman, J., Predicting the intestinal solubility of poorly soluble drugs, in: Pharmacokinetic Profiling in Drug Research , B., Testa, S., Kr¨amer, H., Wunderli-Allenspach, G., Folkers (Eds.) Wiley-VCH, Zurich, 2006, pp. 259–280.
4.Rippie, E.G., Lamb, D.J., Romig, P.W. (1964). Solubilization of weakly acidic and basic drugs by aqueous solutions of polysorbate 80. J. Pharm. Sci ., 53, 1346–1348.
5.Dressman, J.B., PhysChem Forum 5 , 2007.
6.Jinno, J., Oh, D.M., Crison, J.R., Amidon, G.L. (2000). Dissolution of ionizable waterinsoluble drugs: the combined effect of pH and surfactant. J. Pharm. Sci ., 89, 268–274.
7.Avdeef, A., Box, K.J., Comer, J.E., Hibbert, C., Tam, K.Y. (1998). pH-metric logP 10.Determination of liposomal membrane-water partition coefficients of ionizable drugs. Pharm.Res ., 15, 209–215.
8.Miyazaki, J., Hideg, K., Marsh, D. (1992). Interfacial ionization and partitioning of membrane-bound local anesthetics. Biochim. Biophys. Acta, Biomembr ., 1103, 62–68.
9.Avdeef, A., Voloboy, D., Foreman, A., Dissolution and solubility, in Comprehensive Medicinal Chemistry II Volume 5 ADME-Tox Approach , B., Testa, H., vande Waterbeemd (Eds.)Elsevier, Oxford, 2007, pp. 399–423.
10.Serajuddin, A.T.M., Jarowski, C.I. (1985). Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: Salicylic acid,theophylline, and benzoic acid. J. Pharm. Sci ., 74, 148–154.
11.Yang, G., Ran, Y., Yalkowsky, S.H. (2002). Prediction of the aqueous solubility: comparison of the general solubility equation and the method using an amended solvation energy relationship. J. Pharm. Sci ., 91, 517–533.
12.Yalkowsky, S.H., Valvani, S.C. (1980). Solubility and partitioning. I: Solubility of nonelectrolytes in water. J. Pharm. Sci ., 69, 912–922.
13.Jain, N., Yalkowsky, S.H. (2001). Estimation of the aqueous solubility I: application to organic nonelectrolytes. J. Pharm. Sci ., 90, 234–252.
14.Wassvik, C.M., Holmen, A.G., Draheim, R., Artursson, P., Bergstroem, C.A.S. (2008).Molecular characteristics for solid-state limited solubility. J. Med. Chem ., 51, 3035–3039.
15.Wassvik, C.M., Holmen, A.G., Bergstrom, C.A., Zamora, I., Artursson, P. (2006).Contribution of solid-state properties to the aqueous solubility of drugs. Eur. J. Pharm. Sci .,29, 294–305.
16.Zaki, N.M., Artursson, P., Bergstrom, C.A. (2010). A modified physiological BCS for prediction of intestinal absorption in drug discovery. Mol. Pharm ., 7(5), 1478–1487.
17.Lindfors, L., Forssen, S., Skantze, P., Skantze, U., Zackrisson, A., Olsson, U. (2006).Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations. Langmuir , 22, 911–916.
18.Lindfors, L., Forssen, S., Westergren, J., Olsson, U. (2008). Nucleation and crystal growth in supersaturated solutions of a model drug. J. Colloid Interface Sci ., 325, 404–413.
19.Girolami, G.S. (1994). A simple “back of the envelope” method for estimating the densities and molecular volumes of liquids and solids. J. Chem. Educ ., 71, 962–964.
20.Van Eerdenbrugh, B., Vermant, J., Martens, J.A., Froyen, L., Van Humbeeck, J., Van den Mooter, G., Augustijns, P. (2010). Solubility increases associated with crystalline drug nanoparticles: methodologies and significance. Mol. Pharmaceutics , 7, 1858–1870.
21.Good, D.J., Rodrguez-Hornedo, N. (2009). Solubility advantage of pharmaceutical cocrystals. Cryst. Growth Des ., 9, 2252–2264.